ПБиМ 2023 №4 (146)

Maqola mavzusi

COVID-19 И ПОЧКИ: ПОСЛЕДНИЕ ДАННЫЕ (240-244)

Mualliflar

Амонов Мухаммад Комил угли

Muassasa

Бухарский государственный медицинский институт, Республика Узбекистан, г. Бухара

Annotatsiya

Острое повреждение почек (ОПП) является частым осложнением COVID-19, связанным с повышенной смертностью и заболеваемостью. Чаще всего COVID-19 вызывает острый канальцевый некроз; однако в некоторых случаях также были зарегистрированы коллапсирующий фокально-сегментарный гломеру-лосклероз и прямой вирусный тропизм почек. ОПП, вторичная по отношению к COVID-19, имеет много-факторное происхождение. Даже легкое нарушение функции почек является независимым фактором риска заражения COVID-19, госпитализации и смертности. Необходимы дополнительные исследования точного воздействия COVID-19 на почки. Наконец, еще пред-стоит доказать, можно ли улучшить исходы у паци-ентов с заболеванием почек с помощью ожидаемых программ вакцинации.

Kalit so'zlar

Острая почечная недостаточность, хроническая бо-лезнь почек, COVID-19, терминальная стадия почечной недостаточности, гемодиализ, SARSCOV-2.

Adabiyotlar

Kellum JA, van Till JO, Mulligan G (2020) Target-ing acute kidney injury in COVID-19. Nephrol Dial Transplant 35(10):1652–1662 2. Chan L et al (2020) Acute kidney injury in hos-pitalized patients with COVID-19. medRxiv. https://doi. org/ 10. 1101/ 2020. 05. 04. 20090 944 3. Robbins-Juarez SY, et al (2020) Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and metaanalysis. Kidney Int Rep 5(8):1149–1160 4. Kissling S, et al (2020) Collapsing glomerulopa-thy in a COVID-19 patient. Kidney Int 98(1):228–231 5. Kunutsor SK, Laukkanen JA (2020) Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med 52(7):345–353 6. Chen Y-T, et al (2020) Incidence of acute kid-ney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care 24(1):1–4 7. Bowe B, et al (2020) Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19. Clin J Am Soc Nephrol 16(1):14–25. https:// doi. org/ 10. 2215/ CJN. 09610 620 8. Santoriello D, et al (2020) Postmortem kidney pathology findings in patients with COVID-19. J Am Soc Nephrol 31(9):2158–2167. https:// doi. org/ 10. 1681/ASN. 20200 50744 9. Su H, et al (2020) Renal histopathological anal-ysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227 10. Zhou S, et al (2020) Coronavirus- associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review. Ren Fail 43(1):1–15 11. Gupta S, et al (2021) AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol 32(1):161–176. https:// doi. org/ 10. 1681/ ASN. 20200 60897 12. Hirsch JS, et al (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98(1):209–218. https:// doi. org/ 10. 1016/j. kint. 2020. 05. 006 13. Ronco C, Reis T, Husain-Syed F (2020) Man-agement of acute kidney injury in patients with COVID-19. Lancet Respir Med 8(7):738–742 14. Henry BM, Lippi G (2020) Chronic kidney disease is associated with severe coronavirus dis-ease 2019 (COVID-19) infection. Int Urol Neph-rol 52(6):1193–1194. 15. Villanego F, et al (2021) Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: analysis of the Spanish Registry. Am J Transplant 21(7):2573–2582 16. Angelico R, et al (2021) The management of immunosuppression in kidney transplant recipi-ents with COVID-19 disease: an update and sys-tematic review of the literature. Medicina (Kau-nas). 17. Zheng YY, et al (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260. 18. de Simone G (2020) Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers. European Soci-ety of Cardiology 19. de la Cruz A, Ashraf S, Vittorio TJ, Bella JN (2020) COVID-19 and renin-angiotensin system modulators: what do we know so far? Expert Rev Cardiovasc Ther 18(11):743–748 20. Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21 21. Micallef J, Soeiro T, Annie-Pierre JB (2020) Non-steroidal anti-inflammatory drugs, pharma-cology, and COVID-19 infection. Therapies 75(4):355–362 22. Lund LC, et al (2020) Association of non-steroidal anti-inflammatory drug use and adverse outcomes among patients hospitalized with influ-enza. JAMA Netw Open 3(7):e2013880–e2013880 23. Vaja R, et al (2021) The COVID-19 ibuprofen controversy: a systematic review of NSAIDs in adult acute lower respiratory tract infections. Br J Clin Pharmacol 87(3):776–784 24. Bruce E, et al (2020) Prior routine use of non-steroidal anti-inflammatory drugs (NSAIDs) and important outcomes in hospitalized patients with COVID-19. J Clin Med 9(8):2586 25. Kow CS, Hasan SS (2021) The risk of mortali-ty in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammophar-macology 29:1–4 26. Ungprasert P, et al (2015) Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies. Eur J Intern Med 26(4):285–291 27. Schmidt M, et al (2011) Non-steroidal anti-inflammatory drug use and risk of venous throm-boembolism. J Thromb Haemost 9(7):1326–1333 28. Bruchfeld A (2020) The COVID-19 pandem-ic: consequences for nephrology. Nat Rev Neph-rol. 29. Flythe JE, et al (2021) Characteristics and out-comes of individuals with pre-existing kidney dis-ease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis 77(2):190-203.e1. 30. Anand S, et al (2020) Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet 396(10259):1335–1344 31. Couchoud C, et al (2020) Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int 98(6):1519–1529 32. Zeng X, Huang X, Xu L, Xiao J, Gu L, Wang Y, Tuo Y, Fang X, Wang W, Li N (2020) Clinical outcomes of dialysis patients with COVID-19 in the initial phase of the COVID-19 outbreak in Wuhan, China. Int Urol Nephrol 53(2):353–357 33. Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, Gharavi AG, Mohan S, Husain SA (2020) Presentation and out-comes of patients with ESKD and COVID-19. J Am Soc Nephrol 31(7):1409–1415 34. Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sбnchez-Бlvarez JE, Garneata L, Collart F, Hemmelder MH, Ambьhl P, Kerschbaum J (2020) Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis pa-tients and kidney transplant recipients across Eu-rope. Kidney Int 98(6):1540–1548 35. Shang W, Li Y, Li H, Li W, Li C, Cai Y, Dong J (2021) Correlation between laboratory parame-ters on admission and outcome of COVID-19 in maintenance hemodialysis patients. Int Urol Neph-rol 53(1):165–169. https:// doi. org/ 10. 1007/ s11255- 020- 02646-0 36. Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumar O, Lightstone L, Kelleher P, Pickering MC, Thomas D (2020) High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected us-ing serologic screening. J Am Soc Nephrol 31(9):1969–1975 37. Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V (2020) The novel coronavirus 2019 epidemic and kidneys. Kidney Int 97(5):824–828 38. Amonov, Muhammad Komil Ogli. "Risk fac-tors for severe and critical patients with COVID-19" Oriental renaissance: Innovative, educational, natural and social sciences, vol. 1, no. 10, 2021, pp. 1080-1084. 39. К, А. М. (2021). Острое Повреждение По-чек При Коронавирусной Болезни (Обзорная Статья). Central Asian Journal of Medical and Natural Science, 378-382. https://doi.org/10.47494/cajmns.vi0.447 40. Amonov Muhammad Komil o'g'li // Orienta-tion to Acute Kidney Injury in Covid-19 // Vol. 1 No. 5 (2021): Journal of advanced research and stability (JARS)